Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease

Author:

Farias Raysa S.,Silva-Aguiar Rodrigo P.,Teixeira Douglas E.,Gomes Carlos P.,Pinheiro Ana Acacia S.,Peruchetti Diogo B.,Caruso-Neves CelsoORCID

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Publisher

Elsevier BV

Subject

Pharmacology

Reference77 articles.

1. Diabetic kidney disease: challenges, progress, and possibilities;Alicic;Clin. J. Am. Soc. Nephrol.,2017

2. Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis;Ashrafi Jigheh;Iran J. Basic Med. Sci.,2019

3. Sodium-glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice;Cai;Cell Death Dis.,2020

4. PKB and megalin determine the survival or death of renal proximal tubule cells;Caruso-Neves;Proc. Natl. Acad. Sci. U. S. A.,2006

5. SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy;Cassis;JCI Insight,2018

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3